Thread Rating:
  • 2 Vote(s) - 5 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation Population Control, Monitoring & Compliance
11-19-2010, 10:48 PM, (This post was last modified: 11-30-2010, 05:40 AM by FastTadpole.)
Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation Population Control, Monitoring & Compliance
Quote:Bill Gates, co-chair and trustee of the Bill & Melinda Gates Foundation, gave a keynote address yesterday at the mHealth Summit, an annual gathering that focuses on improving health care through mobile technology.

Gates told an audience of more than 2,000 that if we could register every worldwide birth on a cell phone, we could ensure that children receive the proper vaccines. He also said the key to controlling population growth is to save the lives of children under 5; and the next big thing in technology is robots.

Gates said computing technology has been great for health care, and there are plenty of opportunities to use the cell phone in clinic settings. Although he noted that some places which need mhealth technology the most may not be able to fully benefit from it.

“We have to approach these things with some humility,” he said. “There’s not Internet connections back there. Often [patients are too sick] for some cell phone thing to do something for them.”

Gates said the key health care metric that we as a society should be trying to improve is one that is in the front of his mind all the time–the number of children who die before age 5. Today, he said the number is 8.5 million; in 1960 it was 20 million.

“About one-third [of that improvement] is by increasing income,” he said. “The majority has been through vaccines. Vaccines will be the key. If you could register every birth on a cell phone—get fingerprints, get a location—then you could [set up] systems to make sure the immunizations happen.”

Gates said he’d like to see a birth registration system, and because it’s a new technology, “we should let 1,000 new ideas blossom.”

He said vaccination rates in poorer areas, such as northern Nigeria and northern India, are below 50 percent, and mobile technology could make a significant difference.

“When I think about the biggest impacts, I think aobut patient reminders,” Gates said. He explained that technology could help remind people to take the TB drugs regularly or remind mothers to do certain things in their child’s first year of life.

He also said technology will be important in monitoring the supply chain (i.e. making sure there aren’t counterfeits among vaccinations and medications) as well as saving lives on the ground. “Malaria and TB are going to be the first things where you say, ‘Wow, without this mobile application, all these people would have died.’”

Gates told the audience that there is no such thing as a healthy, high-population growth country. “If you’re healthy, you’re low-population growth,” he said.

While most of us assume that saving the lives of children will contribute to overpopulation, Gates said the contrary is true.

“The key thing, the most important fact that people should know and make sure other people know: As you save children under 5, that is the thing that reduces population growth. That sounds paradoxal. The fact is that within a decade of improving health outcomes, parents decide to have less children.

“As the world grows from 6 billion to 9 billion, all of that population growth is in urban slums,” he said. “Slums is a growing businesses. It’s a very interesting problem.”

He said no matter what we care about—the environment, schools, nutrition, conflict—the issues are insoluble at 3 percent population growth per year. “Nobody can handle that type of situation, so the best thing you can do is avoid those deaths.”

He said we are in a tough time for foreign aid, and governments are cutting their budgets in response to the financial climate. “The U.K. is quite exemplary,” he said. “They set aside their aid budget and are on track to keep their commitment. It will grow while they cut the rest of their budget. I hope it doesn’t get cut here in the U.S., but I’ll say I’m quite concerned that it will be.”

Gates said he has resorted to pleading for money. “I’m a beggar now,” he said. “I go around and beg governments for the final [millions of dollars] needed to eradicate polio. The financial component may be why it doesn’t get done.”

When asked what’s next in our technological advancement, Gates said there’s no doubt it’s robots. “If you don’t want to go to a convention,” he said, “just send a robot. “When we look at something like infant mortality, there’s a certain level you can’t get below if you can’t do C-sections.” He said doing a caesarean section delivery requires a sterile environment, but Gates said it’s fairly routine, so it could be done by a robot.

He said that we are moving from computers sitting idle while we type; to those that can see us and have high-end applications; to computers that allow us to move and connect with other users in applications like Xbox.

“Computers are learning to see, learning to talk ,learning to listen, learning to move around,” Gates said. “The dexterity things are maybe five years behind.” But he said once a robot learns a task, “it doesn’t forget how to do it. It can do it 24 hours a day.”

Gates used an example in South Africa to illustrate how health education doesn’t always lead to behavior change. He said the Gates Foundation partnered with the Kaiser Family Foundation to educate young people about HIV, with several types of outreach, including billboards. When interviewed, there was no question that the young people understood what caused HIV, but there were not significant behavior changes, because in their minds, the disease was in the distant future.

“If AIDS killed you immediately, things would be better because you’d see these piles of bodies outside bars [and think], ‘I don’t want to go in there… looks suspicious.’ It’s these discontinuities that are the problem,” Gates said. “If all the poor people lived in your neighborhood we wouldn’t have problems with foreign aid.”
The revolution is not an apple that falls when it is ripe. You have to make it fall. - Che Guevara

Resistance Films Youtube Channel

TriWooOx Podcast
11-23-2010, 03:30 PM,
RE: Bill Gates Wants All New Borns to Be Registrated for Vaccines
Quote:"Vaccines will be the key. If you could register every birth on a cell phone—get fingerprints, get a location—then you could [set up] systems to make sure the immunizations happen." ~ William H. Gates III

Wow no replies on this one I suppose we cannot be shocked anymore with everything that Bill Gates has done to date with pushing the depopulation agenda worldwide.

Bill Gates gives £6.2bn for vaccines for children

Bill Gates Supports Genetically Modified Food and Agriculture

Bill Gates Admits Vaccines Are Used for Human Depopulation

"Doomsday Seed Vault" in the Arctic - Bill Gates, Rockefeller and the GMO giants know something we don’'t

Bill Gates to fund research into 'Flying syringe' mosquitos

Billionaire club in bid to curb overpopulation

Bill Gates funds covert vaccine nanotechnology
There are no others, there is only us.
11-30-2010, 05:34 AM,
RE: Bill Gates Wants All New Borns to Be Registrated for Vaccines
Missed a few depopulation projects Bill Gates is into:

Bill Gates backs ball-busting ultrasound - Grant to probe male contraceptive method

Bill Gates pays for ‘artificial’ clouds to beat greenhouse gases
Seems harmless at first but what else could be launched up besides seawater?

Bill Gates: End-of-Life Care vs. Saving Teachers' Jobs

.. and here's the latest:

Quote:Wash. U. Researcher Plans to Use Bee Venom to Stop Pregnancy, HIV
By Aimee Levitt, Mon., Nov. 29 2010 @ 12:03PM

We've known for years now that unprotected sex can lead to both pregnancy and sexually transmitted diseases, including HIV. We've also known that condoms do a pretty good, but by no means perfect, job of blocking sperm and the HIV virus. But Dr. Sam Wickline of Washington University Medical School has proposed a radical new way of preventing both pregnancy and disease: not by blocking sperm and viruses, but by killing them.

This month Wickline won a $100,000 Grand Challenges Explorations grant from the Bill and Melinda Gates Foundation that will fund the development of a new vaginal antiviral contraceptive gel. Wickline's gel will contain nanoparticles that will target both sperm and HIV and deliver a toxic bee venom that will incapacitate both the cell and the virus.

"Sperm and HIV are remarkably similar in their natural mechanism of genetic transmission," Wickline said in a press release. "Both need to fuse with their target cell in order to deliver their genetic payloads -- DNA in the case of sperm, and RNA in the case of HIV."

The nanoparticles in the gel are synthetic lipids, or fats, created by Wickline and his Wash. U. colleague Dr. Gregory Lanza. They will act as decoys to attract sperm and HIV. When the sperm or virus fuses with the nanoparticles to deliver its DNA or RNA, the nanoparticles will transfer a toxin called melitten that will destroy the sperm of the virus by poking holes in the cell membrane.

Melitten is derived from the venom of the honeybee; hence, the nanoparticles are known as "nanobees."

Of course, there's the problem of how to make sure the nanobees attack only sperm cells and HIV, not other useful cells. Wickline and a colleague, Dr. Paul Schlesinger, tackled this problem two years ago by adding molecules to the nanobees that will bind with receptors only on the target cells.

The nanobees are also too large to leave the vaginal vault and travel to other parts of the body.

Wickline's lab will be working with Kereos, Inc., a St. Louis-based biotech company which Lanza co-founded, to expand the nanobee technology to kill cancer cells.

Grand Challenges Explorations funds research projects to improve global health. Wickline's contraceptive gel would especially benefit women in sub-Saharan Africa, who accounted for 68 percent of new HIV cases in 2008 and have the world's highest fertility rate, with an average of 5.6 children.

Wickline was one of 65 scientists selected for the grant program this month. If he's successful, the Gates Foundation will increase the amount of grant money to up to $1 million.

At least two other labs in the U.S. and Canada are working on similar projects to target and destroy HIV and sperm simultaneously. One proposes using bacteria, the other proteins.

.. and this isn't the only thing that is being funded by GCE in Round 5 of their grant program.

Quote:Press Release
Tuesday, November 9, 2010
Contact: +1.206.709.3400 or

Gates Foundation Funds 65 Novel Ideas to Improve Global Health, From Vaccines Delivered in Local Cuisine to Blankets of Light for Jaundiced Newborns

Researchers from 16 countries selected to explore concepts for new health technologies

SEATTLE – The Bill & Melinda Gates Foundation today announced 65 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support projects in 16 countries with ideas as diverse as a TB vaccine delivered in a traditional Asian bean dish, a mobile phone tool to identify complications for community health workers caring for pregnant women and newborns, and solar powered, therapeutic blankets of light for newborns suffering from jaundice.

“Grand Challenges Explorations is producing innovative ways to tackle ongoing global health challenges like vaccine delivery and caring for mothers and newborns,” said Dr. Tachi Yamada, president of the Gates Foundation’s Global Health Program. “By applying mobile technology and other tools to global health, we hope to produce breakthrough solutions that could save countless lives.”

In five rounds of the foundation’s Grand Challenges Explorations initiative, 405 researchers representing 34 countries have been awarded grants. Projects in this round include developing a synthetic lymph node to deliver vaccines, creating a low cost needle-free treatment for post-partum bleeding, and making a mobile phone-based tool that combines diagnostic testing with economic incentives to improve drug compliance.

These grantees were selected from more than 2,400 proposals. A wide range of disciplines are represented, including applicants from traditional life sciences, public health, engineering, math and computer sciences. They are based at universities, research institutes, hospitals, nonprofit organizations, and private companies around the world.

Project examples include:

Innovative vaccine strategies:

* Michael Chan of the Ohio State Research Foundation will develop a safe strain of the Tuberculosis bacterium and use it to ferment beans used in the traditional Asian dish natto, which could then be eaten as an oral TB vaccine;
* Ali Salanti of the University of Copenhagen in Denmark will develop and test a vaccine combining a novel placental malaria vaccine candidate with the cervical cancer vaccine, with the potential of inducing a strong protective response against both diseases;
* Steven Meshnick and Carla Hand of the University of North Carolina will develop a biodegradable “synthetic lymph node” that could be placed under the skin to deliver more effective vaccines.

Low-cost cell-phone applications for global health:

* Terry Ferrari of World Vision will field test in central Mozambique two mobile phone modules that prompt community health workers caring for pregnant women and newborns to assess, take action, and to refer care in cases of complications and emergencies;
* Mark Thomas of VaxTrac in the U.S. will field test a mobile phone-based vaccination registry that uses fingerprint scans to track those who have received immunizations in hopes of reducing redundant doses and boosting coverage levels in developing countries.

New family health strategies:

* Arye Rosen of AMT, Inc., in the U.S., along with neonatologist Harel Rosen, will test a low-cost, solar-powered portable blanket that can provide light therapy to jaundiced infants;
* Haim Breitbart of Bar-Ilan University in Israel will design and test molecules that would inactivate specific genes within sperm that are essential to the fertilization process to develop a reversible oral male contraceptive.
* Md Abdul Quaiyum of the International Centre for Diarrhoeal Disease Research in Bangladesh will develop and test an inexpensive, biodegradable absorbent mat that can be placed under mothers who have just delivered babies to assess immediate postpartum blood loss. The mat can be weighed at regular intervals to measure absorbed blood, providing easy and early detection of postpartum hemorrhaging.

About Grand Challenges Explorations

Grand Challenges Explorations is a five-year, $100 million initiative to promote innovation in global health. It is part of the Grand Challenges in Global Health initiative, which is supported by the Gates Foundation to achieve major breakthroughs in global health.

Applications for Round 6 of Grand Challenges Explorations will be accepted beginning in March 2011. Details are available at


Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett. Learn more at

For high-resolution still photography and information about the foundation’s work, please visit:
There are no others, there is only us.
11-30-2010, 09:44 AM,
RE: Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation Population Control, Monitoring & Complianc
Full Listing of Grand Challenges Explorations Grants by

Grand Challenges Explorations fosters creative projects that show great promise to improve the health of people in the developing world. Initial grants are awarded two times a year, and successful projects have the opportunity to receive additional funding of up to $1 million.

Here is a listing of all the grants for Vaccines for you to pick through:

There has been a total of 405 Explorations projects to date (show all).

Here are some highlights:

A Mobile Phone Enabled Diagnostic Platform for Monitoring Drug Compliance
Peter Lillehoj and Chih-Ming Ho of the University of California, Los Angeles in the US. will develop a disposable malaria biosensor based on a SIM card platform. This SIM card-biosensor will allow malaria detection to be performed using a cell phone, making diagnostic testing more widely available in rural and decentralized settings.

Cell Based Protocols for Safer Deliveries
Marc Mitchell of D-Tree International in the U.S. will develop and test a mobile phone-based tool using clinical algorithms that rapidly identify women at risk during labor and delivery and facilitate emergency transfer to a hospital. The tool is a combination of phone decision support, data storage, on-line banking and communications on a single device at the point of care to improve maternal health outcomes. If successful, this tool could significantly reduce maternal mortality in low-income countries.

Mobile Phone-Based Biometric Vaccination Registry
Mark Thomas of VaxTrac in the U.S. will field test a mobile phone-based vaccination registry that uses fingerprint scans to track those who have received immunizations in hopes of reducing redundant doses and boosting coverage levels in developing countries.

A Novel Female-Controlled Antiviral Contraceptive
Renjie Chang of Lavax in the U.S. will develop and test a vaginal suppository that uses a strain of commensal bacteria which has the ability to immobilize sperm and capture viruses. If successful, the bacteria could be used as a reversible contraceptive that also affords protection against viruses such as HIV and herpes.

A Novel Nonsurgical Female Sterilization Method, Polidocanol
Jeffrey Jensen of Oregon Health & Science University in the U.S. will test the feasibility of using the varicose vein treatment polidocanol in a foam format to permanently close fallopian tubes. If validated, the method could offer a low-cost, nonsurgical sterilization method for administration by minimally trained healthcare workers in the developing world.

Anti-Microbial/HIV-1 Peptide as a Vaginal Contraceptive
Nongnuj Tanphaichitr of the Ottawa Health Research Institute in Canada will research whether the antimicrobial peptide LL-37 can be used simultaneously as a contraceptive and an anti-HIV treatment. LL-37 binds to specific sites on sperm which are thought not only to play key roles in egg fertilization but also interact with gp120 used by HIV to gain entry into cells.

An Innovative “Inject & Forget” Contraceptive Drug Delivery Device
Gérrard Poinern of Murdoch University in Australia will develop and test an implantable subcutaneous device made from same calcium mineral that bones are made of, which will release contraceptive drugs in a sustained and controlled way for a period of months. Creating of this device uses ultrasound and microwave technology, allowing for eventual low-cost manufacture in developing countries.

The Natural Spermicidal Antimicrobial Subtilosin
Michael Chikindas of Rutgers, The State University of New Jersey in the U.S. will evaluate the effectiveness of the natural antimicrobial protein subtilosin to not only treat vaginal infections but also act as a spermicidal agent. If successful, the protein could be used in a discrete formulation to help women maintain healthy vaginal flora and prevent pregnancy.

Nanotechnology-Based Contraception
David Clapham of Children’s Hospital Boston in the U.S. will develop and test a nanoparticle contraceptive that releases sperm tail inhibitors in response to vaginal pH changes or exposure to prostatic fluid. If successful, the nanoparticles could be incorporated into a vaginal gel to block sperm motility required for fertilization.

Transcervical Reversible Female Contraception
Sujoy Guha of the Indian Institute of Technology in India will test a new transcervical contraceptive made from a polymer compound for its ability to incapacitate both sperm and ovum. The novel compound is delivered to the fallopian tubes in liquid form, changed to a semi-solid form with an external application of radio frequency, and can be flushed out for fast and complete reversibility.

Handheld, Easy to Use Maternal/Fetal Early Warning System
Neil Euliano of Convergent Engineering in the U.S. is developing and testing a maternal-fetal monitoring system that uses reusable capacitive sensors and smart phones that provide early diagnosis for preeclampsia, labor dystocia, and the presence of preterm labor. The system allows time for transportation of these complicated deliveries to a capable facility.

A New Whole-Organism Vaccine Against Malaria
Miguel Prudencio of Instituto de Medicina Molecular in Portugal will test the theory that modified live rodent malaria parasites (P. berghei) can be used in a vaccine to elicit a strong immune response in humans without being able to infect human red blood cells and cause illness.

Bacillus-Fermented Natto as Edible Vaccines for the Developing World
Michael Chan of the Ohio State Research Foundation in the U.S. will develop an engineered strain of bacteria used to ferment beans in traditional Asian and African diets, to display an antigen from the Tuberculosis bacterium. The engineered bacillus will then be used to make the traditional Asian dish natto, which can serve as a kind of oral vaccine to elicit a strong immune response. If successful, this strategy can be used to introduce a variety of disease antigens through culturally accepted foods.

Biological Control of Mosquitoes with Bti-Engineered Algae
David Herrin and colleagues at the University of Texas propose to develop a green-algal food source for mosquito larvae into a biological control agent by engineering their chloroplasts to produce larvacidal proteins**. The chloroplast genome has significant advantages for genetic modification, including stability and containment.

** It also fits with the algae biofuel agenda not only the food source. There is also the huge risk of breeding a larvacidal resistant mosquito.

Could connect with this research
Larvacidal Activity Of Three Ethanol Extract Family Of Labiatae Against Larvae Aedes aegypti and extending it to algae.

Nano-Chip Biosensor for Infectious Diseases & Malaria
Vipul Bansal of RMIT University in Australia will develop a nanochip patch that utilizes a surface enhanced raman scattering (radiation not good humans IMO) platform to detect infectious diseases along with Malaria. The patch will be equipped with micro-needles that when applied to the skin come in close proximity to blood vessels which carry biomarkers for infectious diseases. Using a battery-operated laser scanner, Bansal will detect low concentrations of these molecules due to their unique Raman signature.

Synthetic Lymph Node
Steven Meshnick and Carla Hand of the University of North Carolina in the U.S. will develop a bio-compatible, biodegradable polymer device that can be placed under the skin to introduce vaccines and antigens to the immune system. The device will attract immune cells and trigger their proliferation as well as act as an adjuvant at the site of injection. If successful, the device could help boost immune response to new and existing vaccines.

Use of a Powerful Phage DNA Packaging Motor to Engineer Nanoparticle DNA Vaccines
Venigalla Rao of The Catholic University of America in the U.S. will develop and test a DNA vaccine for HIV that encapsulates multiple HIV envelope genes into bacteriophages that will target antigen presenting dendritic cells. If successful, this could lead to a powerful multivalent DNA vaccine delivery platform against many diseases.

Simple Early Breath Diagnosis of Pneumococcal Pneumonia
Hongyue Dang, of China University of Petroleum (East China) will research whether early-stage pneumonia infection produces specific biomarkers that can be detected in a breath analysis. If so, Dang will produce and test a prototype breath sensor device that can be used in low-resource settings to capture and analyze these signature chemical compounds as a method to diagnose pneumonia.

A Novel Method for Controlling Fertility and STD
John Aitken of the University of Newcastle in Australia will study the mechanisms by which organic compounds called quinones*** may provide simultaneous protection against pregnancy and sexually transmitted disease. Aitken will test the capability of quinones to react to enzymes in semen and not only immobilize sperm, but also disrupt the infective nature of pathogenic microbes found in STD infections such as Chlamydia

*** A quinone is a class of organic compounds that are formally derived from aromatic compounds (such as benzene or naphthalene). .. are often readily made from reactive aromatic compounds with electron-donating substituents such as phenols (such as BPA, Phthalates, Cannabinoids, L-DOPA, Diethylstilbestrol, Capsaicin, Orthophenyl phenol and BHT - full list) and catechols (natural found in tea) which increase the nucleophilicity of the ring and contributes to the large redox potential needed to break aromaticity.

Some phenols are germicidal and are used in formulating disinfectants. Others possess estrogenic or endocrine disrupting activity.~wiki

More on the Cannbinoids Ref:

A Zeolite Hydrogel 'Nano-Mop' For Contraception

**** Zeolites are the aluminosilicate members of the family of microporous solids known as "molecular sieves."

Zeolites are widely used as ion-exchange beds in domestic and commercial water purification, softening, and other applications. Also used in the Petrochemical industry, detergents, nuclear power, solar cells, Heating and refrigeration, concrete, soil treatment, nutritional supplements, and cat litter. Pharma applications include detoxicants and decontaminants, vaccine adjuvants and antibacterial agents. They are also used for delayed release drug delivery, as antitumor adjuvants, as antidiarrheal agents, in hemodialysis, to improve bone formation, and in the treatment of diabetes mellitus.

It does remove heavy metals and radiation as well as absorbing specific nutrients though. Double edged sword.

Ultrasound as a Long-Term, Reversible Male Contraceptive
James Tsuruta and Paul Dayton of the University of North Carolina, Chapel Hill will study the ability of therapeutic ultrasound to deplete testicular sperm counts. Characterizing the most beneficial timing and dosage could lead to the development of a low-cost, non-hormonal and reversible method of contraception for men.

Discovery of Chemosensory Molecules as Novel Contraceptives
John Ngai and Scott Laughlin of the University of California, Berkeley in the U.S. seek to identify chemical compounds in the female reproductive system that guide sperm cells to the egg. By characterizing these “odorants,” synthetic versions can be produced and administered to disrupt this navigation system thus inhibiting fertilization.

POLMITRANSVAC “Pollen Mimetic Transcutaneous Vaccination”
Carlos Alberto Guzman of the Helmholtz Centre for Infection Research in Germany with Claus-Michael Lehr and Steffi Hansen of the Helmholtz-Institute for Pharmaceutical Research will develop and test a vaccine platform that uses a nanoparticle that mimics pollen, which has been shown to be able to penetrate the skin through hair follicles. The nanoparticle will burst upon contact with human sweat, releasing adjuvants and antigens to deliver a vaccine by targeting dendritic cells that surround hair follicles.

Use of Fusobacterium nucleatum as a Vaccine Vector
Youngnim Choi of Seoul National University in the Republic of Korea will test whether Fusobacterium nucleatum, a common bacteria often found in human mouths, can be used to deliver antigens to the oral mucosa. This bacteria has the ability to invade epithelial tissues, and Choi hopes to engineer a strain to express a vaccine antigen when given under the tongue to induce both antibody production and a strong cell-mediated immune response.

Circumcision tool For Traditional Ceremonies In Africa
Kathleen Sienko of the University of Michigan in the U.S. has developed a prototype circumcision tool for use in traditional ceremonies in Africa, and seeks to demonstrate the functionality, cultural suitability, and potential for low-cost mass production of the device. Such a tool could increase the circumcision rates leading to lower rates of HIV transmission in the region.

Sounds like a traumatic way to say welcome to the world.

Insecticide-Treated Traditional Scarves Among Migrants
David Sintasath of Malaria Consortium in Thailand proposes to treat the traditional scarves worn by migrant workers along the Thai-Cambodia border with insecticides to reduce the overall malaria disease burden. Sintasath will then monitor subsequent infection rates reported by area health facilities, and survey participants to learn more about their knowledge, attitude and use of the treated scarves.

Microscope on a Chip
Changhuei Yang of the California Institute of Technology in the U.S. will evaluate the feasibility of using a "microscope on a chip" along with a hand-held reader to detect and analyze cells and parasites in bodily fluids. If successful; this technology, which does not use traditional lenses, could provide diagnostic capabilities for a wide range of diseases including malaria.

Cell Phone Microscopy for Malaria Diagnosis
Daniel Fletcher of the University of California, Berkeley in the U.S. will develop a microscope that attaches to cell phones to capture high-contrast fluorescent images of malaria parasites. Custom software on the phone will automatically count the parasite load, with results and patient information wirelessly transmitted to clinical centers for tracking.

An Immunity-Enhancing Beverage
Steven Maranz of Weill Medical College in the U.S. will test the hypothesis that providing children high levels of flavanols, compounds found in chocolate, green tea, cola and shea nuts, deprives malaria parasites of lipids needed to survive, keeping parasite infection at levels low enough to elicit a strong immune response that builds lifelong immunity.

Brought to you by Coke, Pepsi, Hershey and Cadbury.

Bacterial Viruses as Tool for Blocking Transmission of Malaria
Luiz Ozaki and Gail E. Christie of Virginia Commonwealth University in the U.S. will genetically engineer bacterial viruses to carry peptides that block the development of the malaria parasites, survive in the mosquito gut, and spread through vector populations. If successful, these bacteriophages could be used as “gene dissemination tools” for effective control of the malaria.

Eradication of Malaria through the Development of Host Directed Therapy
Simon Foote of the Menzies Research Institute at the University of Tasmania in Australia will use "forward genetic screening" approaches identify mutations that confer resistance after exposure to malaria parasites. The team will use this powerful information to develop drug therapies that target the human host and mimic these protective genetic effects.

How forward? Babies? Minority Report for defects? Gattaca style for aptitudes?

Malaria Detection Using Earth’s Magnetic Field
Viktor Vegh of The University of Queensland in Australia will test the efficacy of using low-cost nuclear magnetic resonance technologies that take advantage of earth’s magnetic field to detect malaria parasites. The team will examine blood samples to detect hemozoin, a waste product of malarial parasites, to determine the presence of malaria infection

Major NMR instrument makers include Oxford Instruments, Bruker, Spinlock SRL, General Electric, JEOL, Kimble Chase, Philips, Siemens AG and Varian, Inc..~ wiki

MNR uses ELF Radio Waves and is reported to be much safer than MRI or other ferromagnetic scans which do have hazards. Further testing on human health was recommended in 1992. I can't find anything yet though. It's very widely used and sometimes used persistently over wide areas in scans for particles.

Engineered H. pylori as a Diarrheal Vaccine Platform
Martin Blaser of the New York University School of Medicine in the U.S. proposes to engineer a harmless modification of H. pylori, a bacteria commonly found in the human stomach, to deliver antigens to protect against intestinal pathogens such as cholera and campylobacter. This modified H. pylori can only survive in the presence of an enzyme supplied in special drinking water, allowing those administering the vaccine to regulate its colonization.

Reawakening Retrocyclins to Combat Mucosal STIs in Women
Alexander Cole of the University of Central Florida will attempt to restore natural expression of retrocyclins, antiviral peptides whose production in humans has been latent for millions of years. Cole will test inexpensive and widely available antibiotics for their ability to induce production of these retrocyclins, leading to its possible use as a vaginal microbicide.

Not sure if HIV really exists (it's often misdiagnosed and the cocktail of drugs will kill you and lots of people get it without any of the high risk factors) but Retrocyclins are a neat concept. I wonder how it was turned off. Or if it is all a myth.


A Novel Way of Targeting TB using Aptamers and Nanotechnology
To optimize the effectiveness of current anti-tuberculosis drugs, Boitumelo Semete of the CSIR in South Africa will work with collaborators to develop “sticky nanoparticles” that specifically attach to TB-infected cells. Once taken in by these cells, the nanoparticles will slowly degrade, releasing the anti-TB drugs and killing the bacteria. With this novel drug delivery system, the team aims to improve the bioavailability of the current therapies, with the possibility of shortening the treatment period for TB as well as reduce drug side effects.

Toll-Like Receptor 8 Agonists as Novel Neonatal Vaccine Adjuvants
Newborns are at high risk of infection and respond poorly to most vaccines. Ofer Levy at Children’s Hospital Boston in the U.S. will determine whether novel synthetic molecules (imidazoquinolines) are able to activate newborns white blood cells as candidate vaccine adjuvants to dramatically enhance immunization of infants.

Pharma's expanding market for vaccines: newborns less than 4 weeks old.

For viral replication, HIV viruses are dependent upon proteins, called proteases, to appropriately cleave peptides and form functional viral particles. Craig Crews of Yale University in the U.S. will attempt to exploit these proteases by designing a drug that will cleave only to HIV protease and release a cytotoxin that results in programmed cell death.

Programming cell death - the cynic in me sees this as a bad thing, especially when teaming with Bill Gates. This Crews guy looks to be an expert on Angiogenesis either chemically stopping or starting it. Limb regeneration. Immune suppression and activation. Quite the resume.

Therapeutic Pseudovirus Particles to Target Superspreaders
Highly infectious “superspreaders” often drive the spread of infectious agents but are difficult to identify and treat. Leor S. Weinberger of UCSD and James Lloyd-Smith of UCLA will develop and test engineered pseudoviruses called Therapeutic Infectious Particles (TIPs), which conditionally replicate along with the pathogen as it spreads through populations, but have their virulence elements replaced with therapeutic elements that slow down disease progression and curtail transmission.

An entire Section is dedicated to Explore the Basis For Latency in Tuberculosis
Based on this Hypothesis: TB latency is a dynamic process in which a portion of the bacilli, when ingested by macrophages, trigger a genetic program where bacteria cycle between active and latent phases. Understanding whether this dynamic cycle exists could give new insights into maintaining or targeting the latent bacteria, which is the major reservoir of TB globally. ~Maria Lerm of Linkoping University in Sweden

Use of Microwave Frequency as Treatment for Malaria
Because malaria parasites harvest and concentrate iron from blood into their food vacuole, Carmen Spadafora of Panama’s Institute of Advanced Scientific Investigations and High Technology Services will test whether low frequency microwaves, which heat up metal, can destroy the parasites while leaving other cells unharmed.

Cells unharmed is a priority but what of enzymes, proteins, DNA?

A Mutable Vaccine for HIV
Marilia Cascalho of the University of Michigan will test whether a “mutable” DNA vaccine in which the gene coding for the antigen mutates a million times more frequently than a typical gene will trigger immune response that anticipates the production of new viral variants and produces broadly neutralizing antibodies against HIV.

Hyperactivating the immune system in the process.

A Targeted Stealth Weapon of Viral Destruction for HIV
HIV has a very high rate of mutation allowing it to very rapidly develop resistance to AIDS therapies. The essential viral enzyme, HIV reverse transcriptase, lacks a "proofreading" or "repair activity" leading to errors or mutations. Karen Anderson of Yale University is working on "stealth" compounds that have a unique anchor specific for HIV. These compounds encourage the virus to make mutations until the virus is annihilated.

Sounds like a method for giving HIV cancer. You couldn't engineer cancer though, could you?

Stem Cell-Derived Natural Killer Cells as Potent Mediators of Anti-HIV Immunity
Dan Kaufman of the University of Minnesota will test whether natural killer cells, generated from stem cells can effectively target and eliminate HIV-infected cells.

Development of a Single Dose, Multicomponent, Thermostable Vaccine
Using thermostable nanoparticles as a delivery mechanism, Yasmin Thanavala of Health Research Inc and Roswell Park Cancer Institute in the U.S. will work to develop a single dose vaccine that can be given as close to birth as possible to protect against multiple diseases.

Development of a Type III Protein Secretion System as a Quasi-Synthetic Protein Antigen Delivery Nanomachine
Type III protein secretion systems are used by many bacteria to inject proteins into mammalian cells. Jorge Galan of Yale University will develop an antigen delivery machine based on the type III protein delivery system that will not require the use of live-attenuated bacteria, offering a safer vaccine platform.

Genetically Programmed Pathogen Sense and Destroy
Saurabh Gupta and Ron Weiss of Princeton University propose to create sentinel cells that can detect the presence of pathogens, report its identity with a biological signal, and secrete molecules to destroy it.

Novel MucoRice System for the Development of Cold-Chain and Needle/Syringe-Free Vaccine
Hiroshi Kiyono of the University of Tokyo will work to advance a rice-based oral vaccine that can induce both mucosal and systemic immunity. If successful, the MucoRice™ system can be self-administered and will not require syringes or refrigeration.

All 405 are listed here many of which look to be very innovative and have potential to be beneficial. Many can be modified to be weaponized though but if they really wanted to reduce the population so much why wouldn't this have been done already? I think this is more about managing the livestock than a massive wave of death.
There are no others, there is only us.
11-30-2010, 02:49 PM,
RE: Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation Population Control, Monitoring & Complianc
Well that covers $4 Million of the expenditures through the Project that is funded by the Bill and Melinda Gates Foundation. That doesn't cover any of it really if put into perspective.

Many of these projects are grants to kickstart research in Universities and have grants with Government also. Many and are funded by corporations and the Universities themselves. They get a nice tax break on these too.

In looking for that I came across this repository that details tax deductible expenditures by the Bill and Melinda Gates Foundation. Here's a thwack of public documents to flip through.

These ones are the most informative as to the charitible activities of the foundation. It lists them all - lots of education donations and lots for vaccines as well with a few public campaigns sprinkled in.


Quote:$1,581,128,396 (page 673)

Bear mind that there is a lot of lobbying, in fact Bill Gates has equated himself to a beggar in soliciting contributions to causes.
There are no others, there is only us.
03-11-2011, 11:18 PM,
Gates Foundation Invests $10 Million in Vaccines Developer
Makes you wonder if what they term poorer have a better immune system than those living within the civilized cities. Poorer Nations or poor people have adapted to their environment and are in better health than most city dwelling personnel. Maybe this is not helping them, but experiments of the corporate population reduction program in order to take their lands once become weak by vaccinations?? The perfect sense to the globalists…

Gates Foundation Invests $10 Million in Vaccines Developer
By Meg Tirrell - Mar 4, 2011
The Bill & Melinda Gates Foundation invested $10 million in Liquidia Technologies, a closely held biotechnology company developing vaccines, as part of a $400 million initiative to fund activities to help poorer countries.
Liquidia is developing a seasonal flu vaccine and has an agreement with the PATH Malaria Vaccine Initiative to use its technology to work on new malaria vaccines, the Research Triangle Park, North Carolina-based company said today in an e- mailed statement. The $400 million program provides low-interest loans, loan guarantees and equity investments to help finance organizations that meet the group’s focus areas.
Microsoft Corp. (MSFT) Chairman and co-founder Bill Gates, in his 2010 annual foundation letter, highlighted the need for a malaria vaccine to eradicate the disease, calling it “the highest-risk malaria work we fund.” The foundation has supplied $13.8 billion in global health funding since 1994, according to its website.
“Funding innovation is a key to addressing the unmet health needs of the world’s poorest people,” Doug Holtzman, deputy director for the foundation’s infectious diseases team, said in the statement. “This unique investment partnership will help us advance vaccine development as part of our commitment to help research, develop and deliver vaccines for the world’s poorest countries.”
Liquidia investors also include Canaan Partners, New Enterprise Associates, PPD Inc., Morningside Venture Investments Limited, Pappas Ventures and Firelake Capital, according to the statement.
To contact the reporter on this story: Meg Tirrell in New York at
To contact the editor responsible for this story: Reg Gale at
Unite The Many, defeat the few.

Revolution is for the love of your people, culture, knowledge, wisdom, spirit, and peace. Not Greed!
Soul Rebel Native Son
05-19-2011, 11:55 AM,
RE: Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation Population Control, Monitoring & Complianc
Quote:What motivates billionaires like Bill Gates?

Bill Gates now devotes much of his time and money to philanthropy

After interviewing many of the world's richest men, HARDtalk presenter Stephen Sackur ponders the qualities that those billionaires have in common.

Bill Gates may be a billionaire 50 times over, but he is struggling to raise a five-dollar smile. He arrives for our interview with all the enthusiasm of a man about to have his toenails forcibly removed.

But then the cameras roll. Gates powers up, his eyes engage. For half an hour, the founder of Microsoft radiates passionate intelligence.

We are in Geneva for the UN's World Health Assembly, at which Gates is a keynote speaker. He tells me about the progress being made to vaccinate the world's poorest children against many of the most harmful infectious diseases.

The Bill and Melinda Gates Foundation has pledged $10bn (£6.15bn) to scientific research and immunisation programmes to make this the "decade of vaccines".

For those who idly wonder about the difference between being plain rich and being vastly, unimaginably wealthy, here is an answer. Billionaires (and there are more than 1,200 of them, according to the latest Forbes Rich List ) get to think and act on a global scale.

A fortune of $50m will buy luxury homes, fancy cars and a lifetime of ease, but it will not guarantee you a seat at the top table of the world's power elite.

But a billion gives you economic, social and political leverage, should you care to exploit it.

Bill Gates knows that better than most. A billionaire before the age of 32, he's had 25 years to make sense of his fabulous wealth.

For him, and for his wife Melinda, meaning has come in the form of philanthropy. Their foundation has already poured $25bn into public health and development projects around the world.

As his ambitions grew, so did his determination to draw others in. His first convert was Warren Buffett, America's most successful investor, who pledged to drip-feed most of his own immense fortune into the Gates Foundation.

Last year Gates and Buffett devised a Giving Pledge and sought public declarations of support from the world's super-wealthy elite. Sixty-nine individuals have so far promised to give at least half of their assets during their lives or upon their deaths.

"We think a lot of people miss the opportunity to do philanthropy; to do it younger, to get more engaged, to give a higher percentage of their money to it, and part of that is that it's not that easy to learn," says Gates.

"Everybody has a cause, but who do you talk to that has had a similar experience and can really share that overall it's a fun, positive thing."

Gates has recently been to China and India to spread the giving word.
Full Article and Video:
There are no others, there is only us.
02-14-2014, 08:48 PM,
RE: Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation Populati...
Mark Zuckerberg is right on board the agenda with Gates et al.

Quote:Facebook CEO Mark Zuckerberg Donates $992 Million to Charity Funding Planned Parenthood
by Christinia Martin | Washington, DC | | 2/12/14 11:59 AM

Philanthropy magazine released an article titled “A Look at the 50 Most Generous Donors of 2013.” Topping the list was Facebook CEO and co-founder Mark Zuckerberg and his wife, pediatrician Priscilla Chan.

In 2013 the couple donated 18 million shares of Facebook valued at $992.2 million to the Silicon Valley Community Foundation in Mountain View, California. The couple previously donated 19 million Facebook shares to the same foundation in 2012.

markzuckerbergThe Silicon Valley Community Foundation describes its organization as a “comprehensive center of philanthropy.” They partner with donors to fund for profit and non-profit organizations around the globe. On their website you can see a list of words that describe the values of their company. The first word listed is “collaboration.”

This word summarizes the work of Silicon Valley Community; they work as a middle-man between donors and companies, making it easy for donors to get their funds into organizations they support. They accept a number of assets such as real estate, stock, and mutual funds and offer their donors customized philanthropy services.

One of the organizations Silicon Valley Community Foundation collaborates with is Planned Parenthood. A copy of their 2012 Public Disclosure is available for online viewing. The disclosure reports that the SVCF donated over $480,000 to Planned Parenthood in 2012 alone. The donations benefited Planned Parenthoods in multiple cities: San Antonio, TX; New York, NY; San Jose, CA; Jacksonville, FL; and Burlington, VT.The donations ranged in amount from $5,000 to $361,750.

Donations were earmarked under broad terms such as “health,” “supporting families,” and “building community.” The annual donations to Planned Parenthood have almost doubled from 2011, when the SVCF report shows that SVCF gave close to $250,000.

Although Zuckerberg hasn’t publicly commented on the programs their gift will support, he did say their philanthropy would focus on children. Zuckerberg and his wife have every right to spend their money as they see fit. I’m grateful that they are donating to assist children in need. I only hope none of their funds will end up in the big pockets of Planned Parenthood.

As for Silicon Valley Community Foundation, they should cut ties with the taxpayer-funded abortion giant and funnel donations into the hundreds of Pregnancy Resource Centers, Crisis Pregnancy centers and homes for mothers. The Silicon Valley Community Foundation currently has assets of $2.9 billion, more than 1,600 philanthropic funds under management and over 60 local nonprofit partners. One can only dream of the impact those resources could have if directed into pro-life, pro-family, pro-women organizations. Perhaps someone should write Zuckerberg a letter.

Related links FTA:

Care Net

Return of Organization Exempt From Income Tax

Silicon Valley Community Foundation Vision, Mission & Values

No. 1: Mark Zuckerberg and Priscilla Chan
There are no others, there is only us.
02-19-2014, 01:51 AM,
RE: Bill Gates Newborn Vaccine Registration Program + Other Gates Foundation ...
Zucky's interest in children doesn't surprise me. In 2011 I happened across an article on ZoneAlarm titled "Digital FootPrint: A Closer Look At The Age Children Can Use Facebook". Originally available at, I just found it again at

Quote:Mark Zuckerberg: Facebook minimum age limit should be removed

Summary: Facebook CEO Mark Zuckerberg hopes to one day lift the minimum age restriction on the social network, allowing those under 13-years-old to create an account.

By Emil Protalinski for Friending Facebook | May 20, 2011 -- 12:46 GMT (05:46 PDT)
Follow @emilprotalinski

Facebook's Statement of Rights and Responsibilities require users of the social network to be at least 13 years old (and even older, in some jurisdictions). Millions of preteens use the service anyway: some get permission from their parents to create an account while others lie about their age to get past sign-up restrictions. Facebook CEO Mark Zuckerberg wishes there was no limit in the first place.

The Children's Online Privacy Protection Act (COPPA) mandates that websites that collect information about users (like Facebook) aren't allowed to sign on anyone under the age of 13. Zuckerberg wants this changed so that younger kids can be allowed on Facebook, in the name of education. While speaking at a NewSchools Summit in California this week, he outlined how educating kids about the Internet should start at a younger age, and by doing so, we can learn how to make the Internet a safer place for children.

"That will be a fight we take on at some point," Zuckerberg said according to CNN. "My philosophy is that for education you need to start at a really, really young age. Because of the restrictions we haven't even begun this learning process. If they're lifted then we'd start to learn what works. We'd take a lot of precautions to make sure that they [younger kids] are safe."

Two months ago, Facebook announced new safety resources and tools for reporting issues, in conjunction with a White House summit for preventing bullying. Last month, the company rolled them out:

More Resources for Families: the Family Safety Center has been redesigned. There are now more resources, including useful articles for parents and teens and videos on safety and privacy. In the coming weeks, Facebook will also be providing a free guide for teachers, written by safety experts Linda Fogg Phillips, B.J. Fogg and Derek Baird.
Social Reporting Tools: the new social reporting tool (Photo Gallery) allows people to notify a member of their community, in addition to Facebook, when they see something they don't like. By encouraging people to seek help from friends, Facebook hopes that many online issues which are a reflection of what is happening offline can be resolved face to face. This tool launched last month, but Facebook has now expanded it to other parts of the site, including Profiles, Pages, and Groups.

Less than two weeks ago, it was estimated that 7.5 million Facebook users are below the minimum age. To make matters even more worrying, more than 5 million were 10-years-old or younger.
Truth appears in many forms. Find those that resonate with you.

- "If we do not believe in freedom of speech for those we despise, we do not believe in it at all." - Noam Chomsky
- "Humans are not a rational animal, but a rationalizing one." - Leon Festinger - The World In Action

Possibly Related Threads...
Thread Author Replies Views Last Post
  Roddy Piper and mind control stiffy 7 635 06-12-2014, 01:52 AM
Last Post: Watchdog
  The NSA’s Secret Role in the U.S. Assassination Program temp9 1 357 02-14-2014, 04:47 PM
Last Post: thokling
  Documents reveal NSA’s extensive involvement in targeted killing program mexika 0 258 10-18-2013, 08:24 PM
Last Post: mexika
  NSA runs Mind Maping program to predict human behavior mexika 0 408 10-01-2013, 01:25 AM
Last Post: mexika
  Obamas Insider Threat Program - Report your Co-Workers mexika 0 338 06-26-2013, 05:16 AM
Last Post: mexika
  Techniques for dilution, misdirection and control of a internet forum newworlddisorder 0 488 02-26-2013, 01:25 PM
Last Post: newworlddisorder
  The UN asks for control over the world’s Internet TriWooOx 0 396 12-07-2012, 12:21 PM
Last Post: TriWooOx
  Obama gives himself control of all communication systems in America TriWooOx 1 481 07-10-2012, 04:08 PM
Last Post: h3rm35
  This snooping bill is worthy of a surveillance state TriWooOx 0 390 06-17-2012, 10:05 PM
Last Post: TriWooOx
  Lone Democratic(!)Senator Blocks Renewal of NSA Wiretap Program h3rm35 0 406 06-16-2012, 12:25 AM
Last Post: h3rm35

Forum Jump:

Users browsing this thread: 1 Guest(s)